USFDA successfully concludes inspection at Alkem Labs Taloja Bioequivalence Center
Advertisement
Maharashtra: Alkem Labs has recently announced the successful completion of the U.S. Food and Drug Administration (USFDA) inspection of its Taloja facility in Maharashtra.
The inspection was conducted from 11th April to 14th April 2022.
"This is to inform you that USFDA had conducted an inspection at the Company's Bioequivalence Center located at Taloja, Maharashtra from 11th April, 2022 to 14th April 2022," the company said in a BSE filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.